HOUSTON—Five pharmaceutical companies have agreed to pay Louisiana $18.6 million to resolve allegations of misreporting drug price information and overcharging the state’s Medicaid program, Louisiana Attorney General Buddy Caldwell (R) announced Oct. 24.
Drug companies entering civil settlements are Bristol-Myers Squibb, Mylan Inc., Hoffmann-La Roche (Roche), Novo Nordisk Pharmaceuticals, and Shionogi Inc. Caldwell claimed that fraudulent overpricing and marketing of prescription drugs has caused the Louisiana Medicaid program to “grossly overpay for various drug prescriptions.” The attorney general alleged the drug manufacturers provided false and inflated average wholesale prices for their individual drugs.
Bristol-Myers Squibb agreed to pay the state ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.